Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$328M |
| 2 |
Johnson & Johnson
JNJ
|
+$229M |
| 3 |
GE Aerospace
GE
|
+$156M |
| 4 |
Target
TGT
|
+$155M |
| 5 |
Walt Disney
DIS
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$283M |
| 2 |
Eli Lilly
LLY
|
+$211M |
| 3 |
Microsoft
MSFT
|
+$199M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$184M |
| 5 |
Citigroup
C
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.03% |
| 2 | Healthcare | 12.1% |
| 3 | Consumer Discretionary | 11.99% |
| 4 | Consumer Staples | 11.92% |
| 5 | Industrials | 10.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RSO
1101
DELISTED
Resource Capital Corp.
RSO
| $5.52M | 0.01% |
232,325
-177,021
| -43% | -$4.35M |
|
|
INSY
1102
DELISTED
Insys Therapeutics, Inc.
INSY
| $5.52M | 0.01% |
+473,100
| New | +$3.88M |
|
1103
Provident Financial
PROV
$113M
| $5.51M | 0.01% |
331,700
+57,509
| +21% | +$1.01M |
|
|
VRE
1104
DELISTED
Veris Residential
VRE
| $5.51M | 0.01% |
251,100
+9,900
| +4% | +$226K |
|
|
DGIT
1105
DELISTED
DIGITAL GENERATION INC COM STK (DE)
DGIT
| $5.51M | 0.01% |
425,800
-105,968
| -20% | -$1.11M |
|
1106
Brookfield Infrastructure Partners
BIP
$18.2B
| $5.5M | 0.01% |
364,896
-138,852
| -28% | -$2.02M |
|
|
NUTR
1107
DELISTED
Nutraceutical International Co
NUTR
| $5.48M | 0.01% |
230,977
+34,192
| +17% | +$777K |
|
|
BAGL
1108
DELISTED
EINSTEIN NOAH RESTAURANT GROUP, INC CMN STK (DELAWARE)
BAGL
| $5.48M | 0.01% |
316,523
+12,623
| +4% | +$208K |
|
|
ELOS
1109
DELISTED
Syneron Medical Ltd
ELOS
| $5.46M | 0.01% |
632,806
-72,774
| -10% | -$628K |
|
|
FRX
1110
DELISTED
FOREST LABORATORIES INC
FRX
| $5.44M | 0.01% |
127,200
-177,500
| -58% | -$7.71M |
|
|
BKMU
1111
DELISTED
Bank Mutual Corp
BKMU
| $5.44M | 0.01% |
867,253
+137,593
| +19% | +$854K |
|
1112
Sonic Automotive
SAH
$2.56B
| $5.43M | 0.01% |
228,000
-132,500
| -37% | -$3.05M |
|
1113
Woodward
WWD
$21.4B
| $5.42M | 0.01% |
+132,684
| New | +$5.45M |
|
1114
Clearfield
CLFD
$395M
| $5.42M | 0.01% |
403,199
-35,200
| -8% | -$438K |
|
1115
Renasant Corp
RNST
$3.96B
| $5.41M | 0.01% |
199,136
+102,136
| +105% | +$2.71M |
|
1116
Insperity
NSP
$1.92B
| $5.4M | 0.01% |
287,000
-62,000
| -18% | -$1.05M |
|
|
CTB
1117
DELISTED
Cooper Tire & Rubber Co.
CTB
| $5.38M | 0.01% |
174,797
| – | – |
|
|
IVC
1118
DELISTED
Invacare Corporation
IVC
| $5.38M | 0.01% |
311,700
-170,300
| -35% | -$2.7M |
|
1119
First Merchants
FRME
$2.72B
| $5.38M | 0.01% |
310,280
+95,500
| +44% | +$1.71M |
|
|
PTR
1120
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
| $5.38M | 0.01% |
48,900
-242,200
| -83% | -$27.7M |
|
|
SFY
1121
DELISTED
SWIFT ENERGY CO (HOLDING COMPANY)
SFY
| $5.37M | 0.01% |
470,600
+382,500
| +434% | +$4.58M |
|
1122
ArcBest
ARCB
$3.14B
| $5.37M | 0.01% |
208,996
+152,961
| +273% | +$3.67M |
|
|
SVA
1123
DELISTED
Sinovac Biotech, Ltd
SVA
| $5.36M | 0.01% |
896,600
+503,000
| +128% | +$2.4M |
|
|
IQNT
1124
DELISTED
Inteliquent, Inc.
IQNT
| $5.35M | 0.01% |
+553,982
| New | +$4.41M |
|
1125
Compañía de Cervecerías Unidas
CCU
$2.15B
| $5.35M | 0.01% |
201,000
+154,700
| +334% | +$4.29M |
|
Similar funds
Jim Simons's Q3 2013 Portfolio in Review
As of Q3 2013, Jim Simons held 3,196 positions worth $41.2B, up 8.1% from $38.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons's Q3 2013 filing shows 439 new, 1,284 increased, 1,031 reduced and 412 closed positions. Its largest new stake was GE Aerospace: 1,361,721 shares worth $156M. The largest sale was Apple, an estimated $283M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q3 2013 buy was GE Aerospace: 1,361,721 shares worth $156M.
- Jim Simons added most to IBM in Q3 2013, an estimated $328M increase.
- Jim Simons's biggest Q3 2013 reduction was Eli Lilly, cutting an estimated $211M.
- Jim Simons fully exited Apple in Q3 2013, selling an estimated $283M.
- Jim Simons's ten largest holdings make up 11% of its $41.2B portfolio in Q3 2013.
- Jim Simons opened 439 new positions and closed 412 in Q3 2013.
- Jim Simons's portfolio value rose 8.1% quarter-over-quarter to $41.2B.
Based on Renaissance Technologies's 13F filing for Q3 2013, filed 13 Nov 2013.